Nucleocapsid protein of SARS-CoV activates interleukin-6 expression through cellular transcription factor NF-κB
- 1 September 2007
- journal article
- Published by Elsevier BV in Virology
- Vol. 365 (2), 324-335
- https://doi.org/10.1016/j.virol.2007.04.009
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding proteinThe International Journal of Biochemistry & Cell Biology, 2006
- Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirusVirus Research, 2005
- The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domainBiochemical and Biophysical Research Communications, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Up-regulation of p300 Binding and p50 Acetylation in Tumor Necrosis Factor-α-induced Cyclooxygenase-2 Promoter ActivationPublished by Elsevier BV ,2003
- Localization to the Nucleolus Is a Common Feature of Coronavirus Nucleoproteins, and the Protein May Disrupt Host Cell DivisionJournal of Virology, 2001
- Dynamic Shuttling of Nuclear Factor κB between the Nucleus and Cytoplasm as a Consequence of Inhibitor DissociationPublished by Elsevier BV ,2000
- Induction of Interleukin 6 (IL-6) by Hypoxia in Vascular CellsPublished by Elsevier BV ,1995
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990